Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Agena Bioscience’s MassARRAY® System Excels in China Ministry of Health Comparison Study of KRAS Somatic Mutation Detection Methods

Lianxing Yang, Ph.D. and Darryl Irwin*, Ph.D., Agena Bioscience
*Corresponding author: [email protected]


Many laboratories in China are running KRAS mutation detection assays to guide therapy selection for cancer treatment. To promote clinical KRAS mutation detection and improve the quality of laboratory testing, the National Center for Clinical Laboratories (NCCL) of the China Ministry of Health launched a KRAS External Quality Assessment project in 2014. In preparation for the project, the NCCL conducted a preliminary National KRAS Mutation Detection Inter-Lab Quality Evaluation Survey in 2013.

Read the full article now

Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE!

Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine